Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity

Anthracyclines are a class of conventionally and routinely used first-line chemotherapy drugs for cancer treatment. In addition to the direct cytotoxic effects, increasing evidence indicates that the efficacy of the drugs also depends on immunomodulatory effects with unknown mechanisms. Galectin-9 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xian, Wang, Wei-Jan, Lang, Jilu, Yang, Riyao, Shen, Wan-Jou, Sun, Linlin, Hsu, Jung-Mao, Chan, Li-Chuan, Li, Chia-Wei, Xia, Weiya, Ke, Baozhen, Yao, Guodong, Huang, Kebin, Lee, Pei-Chih, Koller, Paul B., Hung, Mien-Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535704/
https://www.ncbi.nlm.nih.gov/pubmed/37781042
http://dx.doi.org/10.7150/ijbs.84108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535704/
https://www.ncbi.nlm.nih.gov/pubmed/37781042
http://dx.doi.org/10.7150/ijbs.84108

Ejemplares similares